Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs.

Mitchell J, Tinkey PT, Avritscher R, Van Pelt C, Eskandari G, Konnath George S, Xiao L, Cressman E, Morris JS, Rashid A, Kaseb AO, Amin HM, Uthamanthil R.

Oncology. 2016;91(2):90-100. doi: 10.1159/000446074. Epub 2016 Jun 16.

2.

Minimizing the perfusion system by integration of the components. Does it affect the hematocrit drop and transfused red blood cells? A retrospective audit.

Boks RH, van Pelt C, Takkenberg JJ, Bogers AJ.

Perfusion. 2015 Mar;30(2):127-31. doi: 10.1177/0267659114536456. Epub 2014 Jun 3.

PMID:
25713163
3.

Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres.

You J, Zhou J, Zhou M, Liu Y, Robertson JD, Liang D, Van Pelt C, Li C.

Part Fibre Toxicol. 2014 May 30;11:26. doi: 10.1186/1743-8977-11-26.

4.

Tissue-specific and age-dependent effects of global Mdm2 loss.

Zhang Y, Xiong S, Li Q, Hu S, Tashakori M, Van Pelt C, You MJ, Pageon L, Lozano G.

J Pathol. 2014 Aug;233(4):380-91. doi: 10.1002/path.4368. Epub 2014 Jun 9.

5.

The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses.

Pijpe A, Slottje P, van Pelt C, Stehmann F, Kromhout H, van Leeuwen FE, Vermeulen RC, Rookus MA.

BMC Cancer. 2014 Jan 29;14:47. doi: 10.1186/1471-2407-14-47.

6.

Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL.

Eefting M, Halkes CJ, de Wreede LC, van Pelt CM, Kersting S, Marijt EW, von dem Borne PA, Willemze R, Veelken H, Falkenburg JH.

Bone Marrow Transplant. 2014 Feb;49(2):287-91. doi: 10.1038/bmt.2013.111. Epub 2013 Aug 12. Erratum in: Bone Marrow Transplant. 2014 Feb;49(2):320.

PMID:
23933760
7.

CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells.

Jacobs ET, Van Pelt C, Forster RE, Zaidi W, Hibler EA, Galligan MA, Haussler MR, Jurutka PW.

Cancer Res. 2013 Apr 15;73(8):2563-73. doi: 10.1158/0008-5472.CAN-12-4134. Epub 2013 Feb 19.

8.

Development and characterization of a novel plug and play liquid chromatography-mass spectrometry (LC-MS) source that automates connections between the capillary trap, column, and emitter.

Bereman MS, Hsieh EJ, Corso TN, Van Pelt CK, Maccoss MJ.

Mol Cell Proteomics. 2013 Jun;12(6):1701-8. doi: 10.1074/mcp.O112.024893. Epub 2013 Feb 19.

9.

A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment.

Frank SJ, Johansen MJ, Martirosyan KS, Gagea M, Van Pelt CS, Borne A, Carmazzi Y, Madden T.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1024-30. doi: 10.1016/j.ijrobp.2012.09.007. Epub 2012 Oct 22.

10.

NHERF1/EBP50 controls lactation by establishing basal membrane polarity complexes with prolactin receptor.

Morales FC, Hayashi Y, van Pelt CS, Georgescu MM.

Cell Death Dis. 2012 Sep 20;3:e391. doi: 10.1038/cddis.2012.131.

11.

Enhancement of lung tumorigenesis in a Gprc5a Knockout mouse by chronic extrinsic airway inflammation.

Barta P, Van Pelt C, Men T, Dickey BF, Lotan R, Moghaddam SJ.

Mol Cancer. 2012 Jan 12;11:4. doi: 10.1186/1476-4598-11-4.

12.

Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release.

You J, Zhang R, Zhang G, Zhong M, Liu Y, Van Pelt CS, Liang D, Wei W, Sood AK, Li C.

J Control Release. 2012 Mar 10;158(2):319-28. doi: 10.1016/j.jconrel.2011.10.028. Epub 2011 Oct 28.

13.

Multiple stress signals activate mutant p53 in vivo.

Suh YA, Post SM, Elizondo-Fraire AC, Maccio DR, Jackson JG, El-Naggar AK, Van Pelt C, Terzian T, Lozano G.

Cancer Res. 2011 Dec 1;71(23):7168-75. doi: 10.1158/0008-5472.CAN-11-0459. Epub 2011 Oct 7.

14.

Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model.

Gupta S, Wright KC, Ensor J, Van Pelt CS, Dixon KA, Kundra V.

Cardiovasc Intervent Radiol. 2011 Oct;34(5):1021-30. doi: 10.1007/s00270-011-0154-6. Epub 2011 Apr 9.

15.

Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.

Kim WY, Kim MJ, Moon H, Yuan P, Kim JS, Woo JK, Zhang G, Suh YA, Feng L, Behrens C, Van Pelt CS, Kang H, Lee JJ, Hong WK, Wistuba II, Lee HY.

Endocrinology. 2011 Jun;152(6):2164-73. doi: 10.1210/en.2010-0693. Epub 2011 Mar 29.

16.

Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E.

Akli S, Van Pelt CS, Bui T, Meijer L, Keyomarsi K.

Cancer Res. 2011 May 1;71(9):3377-86. doi: 10.1158/0008-5472.CAN-10-4086. Epub 2011 Mar 8.

17.

Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4.

Xiong S, Pant V, Suh YA, Van Pelt CS, Wang Y, Valentin-Vega YA, Post SM, Lozano G.

Cancer Res. 2010 Sep 15;70(18):7148-54. doi: 10.1158/0008-5472.CAN-10-1457. Epub 2010 Aug 24.

18.

Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice.

Fujimoto J, Kadara H, Men T, van Pelt C, Lotan D, Lotan R.

PLoS One. 2010 Jul 29;5(7):e11847. doi: 10.1371/journal.pone.0011847.

19.

Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis.

Deng J, Fujimoto J, Ye XF, Men TY, Van Pelt CS, Chen YL, Lin XF, Kadara H, Tao Q, Lotan D, Lotan R.

Cancer Prev Res (Phila). 2010 Apr;3(4):424-37. doi: 10.1158/1940-6207.CAPR-10-0032. Epub 2010 Mar 30.

20.

Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.

Sonnylal S, Shi-Wen X, Leoni P, Naff K, Van Pelt CS, Nakamura H, Leask A, Abraham D, Bou-Gharios G, de Crombrugghe B.

Arthritis Rheum. 2010 May;62(5):1523-32. doi: 10.1002/art.27382.

21.

Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression.

Wingate H, Puskas A, Duong M, Bui T, Richardson D, Liu Y, Tucker SL, Van Pelt C, Meijer L, Hunt K, Keyomarsi K.

Cell Cycle. 2009 Apr 1;8(7):1062-8. Epub 2009 Apr 10.

22.

The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.

Terzian T, Suh YA, Iwakuma T, Post SM, Neumann M, Lang GA, Van Pelt CS, Lozano G.

Genes Dev. 2008 May 15;22(10):1337-44. doi: 10.1101/gad.1662908.

23.

Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.

Tao Q, Fujimoto J, Men T, Ye X, Deng J, Lacroix L, Clifford JL, Mao L, Van Pelt CS, Lee JJ, Lotan D, Lotan R.

J Natl Cancer Inst. 2007 Nov 21;99(22):1668-82. Epub 2007 Nov 13.

PMID:
18000218
24.

Mtbp haploinsufficiency in mice increases tumor metastasis.

Iwakuma T, Tochigi Y, Van Pelt CS, Caldwell LC, Terzian T, Parant JM, Chau GP, Koch JG, Eischen CM, Lozano G.

Oncogene. 2008 Mar 20;27(13):1813-20. Epub 2007 Oct 1.

PMID:
17906694
25.

The p53-Mdm2 network in progenitor cell expansion during mouse postnatal development.

Liu G, Terzian T, Xiong S, Van Pelt CS, Audiffred A, Box NF, Lozano G.

J Pathol. 2007 Dec;213(4):360-8.

PMID:
17893884
26.

Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.

Akli S, Van Pelt CS, Bui T, Multani AS, Chang S, Johnson D, Tucker S, Keyomarsi K.

Cancer Res. 2007 Aug 1;67(15):7212-22.

27.

Loss of Mdm4 results in p53-dependent dilated cardiomyopathy.

Xiong S, Van Pelt CS, Elizondo-Fraire AC, Fernandez-Garcia B, Lozano G.

Circulation. 2007 Jun 12;115(23):2925-30. Epub 2007 May 28.

PMID:
17533180
28.

Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development.

Terzian T, Wang Y, Van Pelt CS, Box NF, Travis EL, Lozano G.

Mol Cell Biol. 2007 Aug;27(15):5479-85. Epub 2007 May 25.

29.
30.

Impaired angiogenesis in aminopeptidase N-null mice.

Rangel R, Sun Y, Guzman-Rojas L, Ozawa MG, Sun J, Giordano RJ, Van Pelt CS, Tinkey PT, Behringer RR, Sidman RL, Arap W, Pasqualini R.

Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4588-93. Epub 2007 Mar 7.

31.

Epidermal stem and progenitor cells in murine epidermis accumulate UV damage despite NER proficiency.

Nijhof JG, van Pelt C, Mulder AA, Mitchell DL, Mullenders LH, de Gruijl FR.

Carcinogenesis. 2007 Apr;28(4):792-800. Epub 2006 Nov 24.

PMID:
17127714
32.

The cell-surface marker MTS24 identifies a novel population of follicular keratinocytes with characteristics of progenitor cells.

Nijhof JG, Braun KM, Giangreco A, van Pelt C, Kawamoto H, Boyd RL, Willemze R, Mullenders LH, Watt FM, de Gruijl FR, van Ewijk W.

Development. 2006 Aug;133(15):3027-37. Epub 2006 Jul 3.

33.

The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts.

Liu Y, Zhang W, Cheung LH, Niu T, Wu Q, Li C, Van Pelt CS, Rosenblum MG.

Neoplasia. 2006 May;8(5):384-93.

34.
35.

Candida krusei transmission among hematology patients resolved by adapted antifungal prophylaxis and infection control measures.

Vos MC, Endtz HP, Horst-Kreft D, Doorduijn J, Lugtenburg E, Verbrugh HA, Löwenberg B, de Marie S, van Pelt C, van Belkum A.

J Clin Microbiol. 2006 Mar;44(3):1111-4.

36.

Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

Xiong S, Van Pelt CS, Elizondo-Fraire AC, Liu G, Lozano G.

Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3226-31. Epub 2006 Feb 21.

37.

Regulated phosphorylation of budding yeast's essential myosin V heavy chain, Myo2p.

Legesse-Miller A, Zhang S, Santiago-Tirado FH, Van Pelt CK, Bretscher A.

Mol Biol Cell. 2006 Apr;17(4):1812-21. Epub 2006 Feb 8.

38.

Use of the i-STAT portable clinical analyzer in mice.

Tinkey P, Lembo T, Craig S, West C, Van Pelt C.

Lab Anim (NY). 2006 Feb;35(2):45-50.

PMID:
16446737
39.

Evaluation of targeted arterial delivery of the branched chain fatty acid 12-methyltetradecanoic acid as a novel therapy for solid tumors.

Wright KC, Yang P, Van Pelt CS, Hicks ME, Collin P, Newman RA.

J Exp Ther Oncol. 2005;5(1):55-68.

PMID:
16416602
40.
41.

Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis.

Lee HY, Oh SH, Woo JK, Kim WY, Van Pelt CS, Price RE, Cody D, Tran H, Pezzuto JM, Moriarty RM, Hong WK.

J Natl Cancer Inst. 2005 Nov 16;97(22):1695-9.

PMID:
16288123
42.

Inhibition of prostate cancer-meditated osteoblastic bone lesions by the low-calcemic analog 1alpha-hydroxymethyl-16-ene-26,27-bishomo-25-hydroxy vitamin D3.

Peleg S, Khan F, Navone NM, Cody DD, Johnson EM, Van Pelt CS, Posner GH.

J Steroid Biochem Mol Biol. 2005 Oct;97(1-2):203-11. Epub 2005 Aug 2.

PMID:
16081281
43.

Chip-based nanoelectrospray mass spectrometry for protein characterization.

Zhang S, Van Pelt CK.

Expert Rev Proteomics. 2004 Dec;1(4):449-68. Review.

PMID:
15966841
44.

Perianal mass in a female transgenic mouse.

Naff KA, Van Pelt C, Craig S, Gray K.

Lab Anim (NY). 2005 Apr;34(4):31, 32-3. No abstract available.

PMID:
15806087
45.

Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression.

Klein RD, Van Pelt CS, Sabichi AL, Dela Cerda J, Fischer SM, Fürstenberger G, Müller-Decker K.

Cancer Res. 2005 Mar 1;65(5):1808-13.

46.

Determination of SCH 211803 by nanoelectrospray infusion mass spectrometry: evaluation of matrix effect and comparison with liquid chromatography-tandem mass spectrometry.

Chen J, Yang L, Kapron JT, Ma L, Pace E, Van Pelt CK, Rudewicz PJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Oct 5;809(2):205-10.

PMID:
15315766
47.

Ethiodized oil-ethanol capillary embolization in rabbit kidneys: temporal histopathologic findings.

Kónya A, Van Pelt CS, Wright KC.

Radiology. 2004 Jul;232(1):147-53.

PMID:
15220499
48.
49.

Strict infection control measures do not prevent clonal spread of coagulase negative staphylococci colonizing central venous catheters in neutropenic hemato-oncologic patients.

van Pelt C, Nouwen J, Lugtenburg E, van der Schee C, de Marie S, Schuijff P, Verbrugh H, Löwenberg B, van Belkum A, Vos M.

FEMS Immunol Med Microbiol. 2003 Sep 22;38(2):153-8.

50.

Supplemental Content

Loading ...
Support Center